These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


90 related items for PubMed ID: 18375545

  • 1. Species-specific kinetics and zonation of hepatic DNA synthesis induced by ligands of PPARalpha.
    Al Kholaifi A, Amer A, Jeffery B, Gray TJ, Roberts RA, Bell DR.
    Toxicol Sci; 2008 Jul; 104(1):74-85. PubMed ID: 18375545
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes.
    Ammerschlaeger M, Beigel J, Klein KU, Mueller SO.
    Toxicol Sci; 2004 Apr; 78(2):229-40. PubMed ID: 14976357
    [Abstract] [Full Text] [Related]

  • 4. Cell cross-talk mediates PPARalpha null hepatocyte proliferation after peroxisome proliferator exposure.
    Weglarz TC, Sandgren EP.
    Carcinogenesis; 2004 Jan; 25(1):107-12. PubMed ID: 14514660
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha.
    Cook WS, Yeldandi AV, Rao MS, Hashimoto T, Reddy JK.
    Biochem Biophys Res Commun; 2000 Nov 11; 278(1):250-7. PubMed ID: 11071880
    [Abstract] [Full Text] [Related]

  • 9. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.
    Cariello NF, Romach EH, Colton HM, Ni H, Yoon L, Falls JG, Casey W, Creech D, Anderson SP, Benavides GR, Hoivik DJ, Brown R, Miller RT.
    Toxicol Sci; 2005 Nov 11; 88(1):250-64. PubMed ID: 16081524
    [Abstract] [Full Text] [Related]

  • 10. Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes.
    Hong JT, Glauert HP.
    J Cell Physiol; 1996 Nov 11; 169(2):309-19. PubMed ID: 8908198
    [Abstract] [Full Text] [Related]

  • 11. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
    Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM.
    Carcinogenesis; 2005 Jan 11; 26(1):219-27. PubMed ID: 15447978
    [Abstract] [Full Text] [Related]

  • 12. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA.
    Toxic Rep Ser; 1999 Aug 11; (59):1-66, A1-E7. PubMed ID: 11803702
    [Abstract] [Full Text] [Related]

  • 13. Effects of peroxisome proliferator-activated receptor alpha activation on pathways contributing to cholesterol homeostasis in rat hepatocytes.
    Le Jossic-Corcos C, Duclos S, Ramirez LC, Zaghini I, Chevillard G, Martin P, Pineau T, Bournot P.
    Biochim Biophys Acta; 2004 Jul 05; 1683(1-3):49-58. PubMed ID: 15238219
    [Abstract] [Full Text] [Related]

  • 14. Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor alpha synthetic ligands in mouse liver.
    Guo D, Sarkar J, Suino-Powell K, Xu Y, Matsumoto K, Jia Y, Yu S, Khare S, Haldar K, Rao MS, Foreman JE, Monga SP, Peters JM, Xu HE, Reddy JK.
    J Biol Chem; 2007 Dec 14; 282(50):36766-76. PubMed ID: 17962186
    [Abstract] [Full Text] [Related]

  • 15. Role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver.
    Laughter AR, Dunn CS, Swanson CL, Howroyd P, Cattley RC, Corton JC.
    Toxicology; 2004 Oct 15; 203(1-3):83-98. PubMed ID: 15363585
    [Abstract] [Full Text] [Related]

  • 16. Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin.
    Holden PR, Hasmall SC, James NH, West DR, Brindle RD, Gonzalez FJ, Peters JM, Roberts RA.
    Cell Mol Biol (Noisy-le-grand); 2000 Feb 15; 46(1):29-39. PubMed ID: 10726969
    [Abstract] [Full Text] [Related]

  • 17. Induction of pancreatic acinar cell proliferation by thyroid hormone.
    Ledda-Columbano GM, Perra A, Pibiri M, Molotzu F, Columbano A.
    J Endocrinol; 2005 Jun 15; 185(3):393-9. PubMed ID: 15930165
    [Abstract] [Full Text] [Related]

  • 18. IL-6 cooperates with peroxisome proliferator-activated receptor-α-ligands to induce liver fatty acid binding protein (LFABP) up-regulation.
    Vida M, Serrano A, Romero-Cuevas M, Pavón FJ, González-Rodriguez A, Gavito AL, Cuesta AL, Valverde AM, Rodríguez de Fonseca F, Baixeras E.
    Liver Int; 2013 Aug 15; 33(7):1019-28. PubMed ID: 23534555
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-induced alterations in the expression and modification of rat hepatocyte plasma membrane proteins.
    Bartles JR, Khuon S, Lin XH, Zhang LQ, Reddy JK, Rao MS, Isoye ST, Nehme CL, Fayos BE.
    Cancer Res; 1990 Feb 01; 50(3):669-76. PubMed ID: 2404574
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.
    Goll V, Alexandre E, Viollon-Abadie C, Nicod L, Jaeck D, Richert L.
    Toxicol Appl Pharmacol; 1999 Oct 01; 160(1):21-32. PubMed ID: 10502499
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.